An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine

An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine

BNT162b2, an mRNA-based SARS-CoV-2 vaccine (Pfizer-BioNTech, New York, NY, USA), is one of the most effective COVID-19 vaccines and has been approved by more than 130 countries worldwide. However, several studies have reported that the COVID-19 vaccine shows high interpersonal variability in terms o...

Full description

Bibliographic Details
Main Authors: Seik-Soon Khor, Yosuke Omae, Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura, Katsushi Tokunaga
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
Pfizer-BioNTech
IgG
HLA
Japanese
Online Access:https://www.mdpi.com/2076-393X/10/4/563

Internet

https://www.mdpi.com/2076-393X/10/4/563

Similar Items